Dr. Simone Perazzolo, a scientist in the TLC-ART Program, was featured on Italian national TV explaining how an FDA approved protease inhibitor called Lopinavir (Kaletra) may be effective against Covid-19 since requires protease enzymes to replicate.
He has highlighted targeted and long-acting drug combinations containing Lopinavir + Tenofovir (HIV and Hepatitis B drugs) currently in late-stage development for human testing by TLC-ART. This therapy may potentially replace 30-60 daily pills with a single injection.
Please follow the video link for the full interview.